Pericarditis

Pericarditis is an inflammation of the pericardium, the two-layered sac-like membrane that surrounds the heart. This inflammation can lead to chest pain and, in some cases, fluid accumulation (pericardial effusion) around the heart. While often acute and self-limiting, pericarditis can recur or lead to severe complications such as cardiac tamponade or constrictive pericarditis if not properly managed.

The most common cause of pericarditis is viral infection (e.g., Coxsackievirus, adenovirus, influenza, echovirus, HIV). Other etiologies include bacterial infections (tuberculosis, purulent pericarditis), fungal infections, and parasitic infections. Non-infectious causes include autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis), uremia (kidney failure), myocardial infarction (Dressler's syndrome), trauma (e.g., cardiac surgery, chest injury), radiation therapy, certain medications (e.g., procainamide, hydralazine, phenytoin), and malignancies. In a significant number of cases, the cause remains unknown, classified as idiopathic pericarditis.

Inflammation of the pericardium leads to increased vascular permeability, resulting in the exudation of fluid, fibrin, and inflammatory cells into the pericardial space. This process causes the characteristic chest pain. If the fluid accumulation (pericardial effusion) is rapid or substantial, it can impede the heart's filling, leading to cardiac tamponade. Chronic inflammation or recurrent episodes can lead to thickening and scarring of the pericardium, potentially resulting in constrictive pericarditis, where the rigid pericardium restricts diastolic filling of the ventricles, impairing cardiac output.

Pericarditis is relatively common, accounting for about 0.1% of hospital admissions and 5% of emergency department presentations for chest pain. It primarily affects young to middle-aged adults, with a slight male predominance. Incidence rates vary globally but are estimated at 10-20 cases per 100,000 individuals per year. Recurrent pericarditis occurs in 15-30% of patients after an initial episode.

• Viral infections
• Autoimmune diseases (e.g., SLE, RA)
• Kidney failure (uremia)
• Recent myocardial infarction or cardiac surgery
• Malignancy (primary or metastatic)
• Tuberculosis
• Trauma to the chest or heart
• Radiation therapy to the chest
• Certain medications (e.g., procainamide, hydralazine)

A. Early Symptoms

• Sudden onset, sharp, pleuritic chest pain


• Pain often retrosternal, radiating to the neck, shoulders, or trapezius ridge


• Pain typically worsens with deep inspiration or lying flat


• Pain relieved by sitting up and leaning forward B. Common Symptoms


• Dyspnea (shortness of breath)


• Low-grade fever


• Malaise and fatigue


• Cough


• Myalgia or arthralgia C. Advanced Symptoms


• Peripheral edema (swelling)


• Significant fatigue and weakness


• Reduced exercise tolerance


• Abdominal distention (ascites) - in constrictive pericarditis D. Emergency Symptoms


• Severe, crushing chest pain unrelieved by positional changes


• Syncope or near-syncope (fainting)


• Profound dyspnea at rest


• Signs of shock (hypotension, tachycardia, cold extremities)


• Cyanosis

Vital signs may show fever, tachycardia, and hypotension (if tamponade is present). Inspection may reveal elevated jugular venous pressure (JVP) and Kussmaul's sign (paradoxical rise in JVP with inspiration) in constrictive pericarditis or tamponade. Auscultation often reveals a characteristic pericardial friction rub (a scratchy, superficial sound, often triphasic, heard best at the left sternal border). Distant or muffled heart sounds may be present with large pericardial effusions. Pulsus paradoxus (an inspiratory decrease in systolic blood pressure >10 mmHg) is a key finding in cardiac tamponade.

A. Clinical Assessment
Detailed history of chest pain characteristics, associated symptoms, and medical history. Physical examination to identify friction rub, JVP, and signs of effusion or tamponade. B. Laboratory Testing
To assess inflammation, rule out myocardial injury, and identify etiology. C. Imaging Studies
To visualize the pericardium, detect effusion, and assess cardiac function. D. Functional Tests
Not routinely used for initial diagnosis; may be considered in specific cases. E. Biopsy Findings
Pericardial biopsy is reserved for cases where specific etiologies (e.g., tuberculosis, malignancy) are suspected and cannot be diagnosed by less invasive means. F. Genetic Testing
Not indicated for typical pericarditis. May be considered for rare genetic causes of associated conditions. G. Differential Diagnosis
Myocardial infarction, pulmonary embolism, pleurisy, gastroesophageal reflux disease, musculoskeletal chest pain, acute cholecystitis.

Complete Blood Count (CBC)
Type: Blood Test
Purpose: To check for leukocytosis (elevated white blood cell count), indicating infection.
Expected Findings: May show leukocytosis, especially in bacterial or severe viral infections.
Interpretation: Elevated WBC suggests an infectious etiology. Erythrocyte Sedimentation Rate (ESR) & C-Reactive Protein (CRP)
Type: Blood Test
Purpose: To assess systemic inflammation.
Expected Findings: Elevated levels.
Interpretation: Non-specific markers of inflammation, typically elevated in acute pericarditis. CRP is generally more sensitive and specific. Cardiac Troponin I or T
Type: Blood Test
Purpose: To rule out myocardial injury (myocarditis) or infarction.
Expected Findings: May be mildly elevated in pericarditis, significantly elevated in myocarditis or MI.
Interpretation: Mild elevation (<2-3x upper limit) may occur with epicardial inflammation (myopericarditis); high levels suggest significant myocardial involvement. Blood Urea Nitrogen (BUN) and Creatinine
Type: Blood Test
Purpose: To assess kidney function and rule out uremic pericarditis.
Expected Findings: Elevated in kidney failure.
Interpretation: Significantly elevated levels support a diagnosis of uremic pericarditis. Antinuclear Antibody (ANA) / Rheumatoid Factor (RF)
Type: Blood Test
Purpose: To screen for autoimmune conditions.
Expected Findings: May be positive in autoimmune diseases.
Interpretation: Positive results suggest an underlying autoimmune cause for pericarditis. Thyroid Stimulating Hormone (TSH)
Type: Blood Test
Purpose: To screen for hypothyroidism.
Expected Findings: Elevated in hypothyroidism.
Interpretation: Hypothyroidism can rarely cause pericardial effusion.

Electrocardiogram (ECG)
Purpose: To assess electrical activity of the heart.
Typical Findings: Diffuse, concave-upward ST segment elevation in most leads (except aVR and V1), PR segment depression (especially in limb leads and V2-V6). Low voltage QRS complexes and electrical alternans may indicate a large pericardial effusion.
Clinical Importance: Characteristic ECG changes are crucial for diagnosis and differentiating from myocardial infarction. Echocardiography (ECHO)
Purpose: To visualize the pericardium, heart chambers, and assess cardiac function.
Typical Findings: Pericardial effusion (quantifies size and distribution), signs of cardiac tamponade (right ventricular collapse in diastole, right atrial collapse in systole), evidence of constrictive pericarditis (pericardial thickening, septal bounce, respirophasic variation in ventricular inflow).
Clinical Importance: The most important imaging modality for diagnosis, assessing severity, guiding pericardiocentesis, and monitoring. Chest X-ray (CXR)
Purpose: To check for cardiomegaly or pulmonary issues.
Typical Findings: Often normal in mild pericarditis. May show an enlarged cardiac silhouette ("water bottle heart") with very large pericardial effusions (>200-300mL). Lung fields are usually clear.
Clinical Importance: Less sensitive than ECHO but can suggest large effusions and rule out pulmonary causes of chest pain. Cardiac Computed Tomography (CT) / Magnetic Resonance Imaging (MRI)
Purpose: To provide detailed anatomical imaging of the pericardium.
Typical Findings: Pericardial thickening, enhancement with contrast (inflammation), calcification, and detailed assessment of pericardial effusion and its loculation.
Clinical Importance: Valuable for diagnosing constrictive pericarditis, differentiating it from restrictive cardiomyopathy, and identifying specific pericardial lesions (e.g., masses, calcifications) or complex effusions.

• Myocardial Infarction (MI): Pericarditis pain is pleuritic, positional, and relieved by leaning forward, while MI pain is typically crushing, substernal, and not positional. ECG in pericarditis shows diffuse ST elevation and PR depression; MI shows localized ST elevation with reciprocal changes and often Q waves.
• Pulmonary Embolism (PE): PE causes sudden dyspnea and pleuritic chest pain, but typically without friction rub or diffuse ECG changes of pericarditis. Tachycardia and hypoxemia are common in PE.
• Pleurisy: Inflammatory chest pain, similar to pericarditis, but usually localized to the chest wall, exacerbated by breathing, and without systemic signs of cardiac involvement (no friction rub, specific ECG changes).
• Gastroesophageal Reflux Disease (GERD): Burning retrosternal pain, often worse after meals or at night, relieved by antacids. Lacks characteristic pericardial symptoms or signs.
• Musculoskeletal Chest Pain: Localized tenderness on palpation of the chest wall, pain reproduced with specific movements.

• Pericardial Effusion: Accumulation of fluid in the pericardial space, which can be mild to severe.
• Cardiac Tamponade: Life-threatening compression of the heart due to rapid or large pericardial effusion, impeding cardiac filling and output.
• Recurrent Pericarditis: Occurs in 15-30% of patients, defined as a relapse after a symptom-free interval of 4-6 weeks.
• Constrictive Pericarditis: Chronic condition where the pericardium becomes thick, fibrotic, and calcified, restricting diastolic heart filling and leading to heart failure symptoms.
• Myopericarditis: Inflammation extending from the pericardium to the adjacent myocardium, leading to elevated cardiac enzymes and potential myocardial dysfunction.

A. Lifestyle Modifications
Rest is crucial during the acute phase. Avoid strenuous physical activity and competitive sports until symptoms resolve and inflammatory markers normalize, typically for 3 months or longer, to prevent recurrence and progression to myocarditis. B. Preventive Measures
Treating underlying conditions (e.g., autoimmune diseases, kidney failure) and avoiding unnecessary cardiac procedures can reduce risk. Influenza vaccination may prevent some viral causes. C. Medical Treatment
| Drug Class | Mechanism of Action | Examples |
| :-------------------- | :------------------------------------------------------- | :----------------------- |
| NSAIDs | Inhibit prostaglandin synthesis, reducing inflammation. | Ibuprofen, Indomethacin |
| Colchicine | Antimitotic and anti-inflammatory effects. | Colchicine |
| Corticosteroids | Potent anti-inflammatory and immunosuppressive agents. | Prednisone |
| Immunosuppressants | Suppress immune response. | Azathioprine, Methotrexate |
| IL-1 Receptor Antagonists | Blocks IL-1 beta, a key pro-inflammatory cytokine. | Anakinra | D. Surgical Treatment

• Pericardiectomy: Surgical removal of the thickened, rigid pericardium. Indicated for chronic constrictive pericarditis unresponsive to medical therapy.


• Pericardial Window: Creation of an opening in the pericardium to drain recurrent or persistent pericardial effusions into the pleural space or peritoneum. E. Interventional Procedures


• Pericardiocentesis: Percutaneous drainage of pericardial fluid using a needle and catheter, guided by echocardiography. Performed to relieve cardiac tamponade or for diagnostic fluid analysis. F. Rehabilitation

The prognosis for acute viral or idiopathic pericarditis is generally good, with most patients recovering completely within weeks. However, up to 30% may experience recurrent episodes. The prognosis is less favorable in cases with underlying autoimmune disease, malignancy, or tuberculosis. Constrictive pericarditis has a more guarded prognosis and often requires surgical intervention. Mortality rates are low for acute pericarditis but increase significantly with complications like cardiac tamponade or constrictive pericarditis if untreated.

Primary prevention focuses on treating underlying conditions that may predispose to pericarditis, such as autoimmune diseases or kidney failure. Vaccinations against common viral pathogens (e.g., influenza) may reduce the risk of viral pericarditis. Secondary prevention involves appropriate and prolonged anti-inflammatory treatment (e.g., NSAIDs and colchicine) for acute episodes to reduce the risk of recurrence and close monitoring during the initial recovery phase to detect complications early. Avoiding strenuous exercise during acute inflammation is crucial.

The following homeopathic remedies have been historically indicated for symptoms associated with Pericarditis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Pericarditis.